[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-341474-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-341474-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","effect-of-medicaid-expansion-on-cancer-treatment-and-survival-among-medicaid-beneficiaries-and-the-uninsured","Effect of Medicaid expansion on cancer treatment and survival among Medicaid beneficiaries and the uninsured","","The Affordable Care Act expanded Medicaid coverage for low-income people in the United States, potentially enabling more timely cancer treatment and improving overall survival, though long-term effects remained unclear. This study evaluated whether Medicaid expansion (ME) improved timely treatment initiation and 3-year overall survival among patients with breast, cervical, colon, and non-small cell lung cancers. Using Medicaid-insured and uninsured patients aged 40–64 in the National Cancer Database and a difference-in-differences design, adjusted estimates assessed changes in timely treatment within 60 days and survival before versus after ME implementation.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/effect-of-medicaid-expansion-on-cancer-treatment-and-survival-among-medicaid-beneficiaries-and-the-uninsured/341474/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/effect-of-medicaid-expansion-on-cancer-treatment-and-survival-among-medicaid-beneficiaries-and-the-uninsured/341474.png","ImageObject",300,407,{"name":42,"@type":43},"Liam","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What was the study’s main goal regarding Medicaid expansion?","Question",{"text":63,"@type":64},"To determine whether Medicaid expansion was associated with improved timely treatment initiation and 3-year overall survival among patients with several common cancers who were affected by the policy.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How did the researchers measure timely treatment and survival?",{"text":68,"@type":64},"They assessed timely treatment initiation within 60 days and compared 3-year overall survival using adjusted difference-in-differences estimates and regression-based models.",{"name":70,"@type":61,"acceptedAnswer":71},"Which cancer types showed significant associations with Medicaid expansion outcomes?",{"text":72,"@type":64},"Medicaid expansion was associated with increased timely treatment initiation for breast, cervical, and colon cancers. For survival, improved 3-year overall survival was found for breast, cervical, and lung cancers, while colon cancer survival changes were not statistically different.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},341474,1790642753,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},8796095461564,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","DOI: 10. 1002/cam4 .7461  \nRESEAR CH ARTICLE  \nEffect of Medicaid expansion on cancer treatment and survival among Medicaid beneficiaries and the uninsured  \nKristin M. Primm1,2  | Hui Zhao3  | Naomi N. Adjei4 | Charlotte C. Sun4 | Alen Haas3 | Larissa A. Meyer4 | Shine Chang1  \n1Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA 2Department of Epidemiology and Biostatistics, The University of California San Francisco, San Francisco, California, USA 3Department of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA  \n4Department of Gynecologic Oncology and Reproductive Medicine, The  \nUniversity of Texas MD Anderson Cancer Center, Houston, Texas, USA  \nCorrespondence  \nKristin M. Primm, Department of Epidemiology and Biostatistics, The University of California San Francisco, 550 16th St, San Francisco, CA 94158, USA.  \n[Email:](Email: kristie.primm@ucsf.edu)[ kristie.primm@ucsf.edu](Email: kristie.primm@ucsf.edu)  \nFunding information  \nCancer Prevention and Research Institute of Texas, Grant/Award Number: RP 170259; National Institutes of Health, Grant/Award Number: T32CA101642  \nAbstract  \nBackground: The Affordable Care Act expanded Medicaid coverage for people with low income in the United States. Expanded insurance coverage could promote more timely access to cancer treatment, which could improve overall survival (OS), yet the long-term effects of Medicaid expansion (ME) remain unknown. We evaluated whether ME was associated with improved timely treatment initiation (TTI) and 3-year OS among patients with breast, cervical, colon, and lung cancers who were affected by the policy.  \nMethods: Medicaid-insured or uninsured patients aged 40–64 with stage I–III breast, cervical, colon, or non-small cell lung cancer within the National Cancer Database (NCDB). A difference-in-differences (DID) approach was used to compare changes in TTI (within 60 days) and 3-year OS between patients in ME states versus nonexpansion (NE) states before (2010–2013) and after (2015–2018) ME. Adjusted DID estimates forTTI and 3-year OS were calculated using multivariable linear regression and Cox proportional hazards regression models, respectively. Results: ME was associated with a relative increase in TTI within 60 days for breast (DID = 4.6; p \u003C0.001), cervical (DID = 5.0 p = 0.013), and colon (DID = 4.0, p = 0.008), but not lung cancer (p = 0.505) . In Cox regression analysis, ME was associated with improved 3-year OS for breast (DID hazard ratio [HR] = 0.82, p = 0.009), cervical (DID-HR = 0.81, p = 0.048), and lung (DID-HR = 0.87, p = 0.003) . Changes in 3-year OS for colon cancer were not statistically different between ME and NE states (DID-HR, 0.77; p = 0.075) .  \nConclusions: Findings suggest that expanded insurance coverage can improve treatment and survival outcomes among low income and uninsured patients with cancer. As the debate surrounding ME continues nationwide, our findings serve as valuable insights to inform the development of policies aimed at fostering accessible and affordable healthcare for all.  \nKEYWORDS  \nbreast cancer, colorectal cancer, epidemiology and prevention, non small cell lung cancer, medicaid expansion, survival  \nThis is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.  \n© 2024 The Author(s). Cancer Medicine published by John Wiley & Sons Ltd.  \nCancer Medicine. 2024;13:e7461 .  \n[https://doi.org/10.1002/cam4.7461](https://doi.org/10.1002/cam4.7461)  \n[wileyonlinelibrary.com/journal/cam4](wileyonlinelibrary.com/journal/cam4)  \n1 of 11  \n1 | INTRODUCTION  \nMedicaid expansion (ME) was a key provision of the Affordable Care Act (ACA) that allowed states the option to extend Medicaid eligibility to individuals with incomesup to 138% of the federal poverty level.1,2 Unlike other ACA ","cbCaisBTXXDtQoTF","https://ap.wps.com/l/cbCaisBTXXDtQoTF","pdf",720454,11,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Introduction\n## Medicaid expansion as a natural experiment\n## Insurance coverage and cancer care access\n## Rationale for evaluating timely treatment and survival","[{\"question\":\"What was the study’s main goal regarding Medicaid expansion?\",\"answer\":\"To determine whether Medicaid expansion was associated with improved timely treatment initiation and 3-year overall survival among patients with several common cancers who were affected by the policy.\"},{\"question\":\"How did the researchers measure timely treatment and survival?\",\"answer\":\"They assessed timely treatment initiation within 60 days and compared 3-year overall survival using adjusted difference-in-differences estimates and regression-based models.\"},{\"question\":\"Which cancer types showed significant associations with Medicaid expansion outcomes?\",\"answer\":\"Medicaid expansion was associated with increased timely treatment initiation for breast, cervical, and colon cancers. For survival, improved 3-year overall survival was found for breast, cervical, and lung cancers, while colon cancer survival changes were not statistically different.\"}]","Effect of Medicaid expansion on cancer treatment and survival among Medicaid beneficiaries and the uninsured | PDF",1790042043,28,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/93c67b59c60a6dd7643376fa446e0f93.webp",983,1291,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fc5d273d717c2ab021690fc55477c3de.webp",982,1290,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/99fa56558556336e07618019ea88ea29.webp",981,1289,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1f3b82a4826d8cfeede15c8a0c8ebeef.webp",980,1287]